CME

Evolutionary Approaches to the Patient with Pulmonary Arterial Hypertension

Jointly Provided by the University of Cincinnati and PlatformQ Health, Inc.

ACKNOWLEDGEMENT
This activity is supported by educational grants provided by Actelion Pharmaceuticals US, Inc. and Bayer HealthCare Pharmaceuticals, Inc.

TUITION
Complimentary

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and PlatformQ Health Education, LLC. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS
Live Internet Activity
The University of Cincinnati designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

The University of Cincinnati designates this Enduring Material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF RELEASE/EXPIRATION
Live Activity
Tuesday, June 28, 2016, 10:00 AM - 11:00 AM EST

Enduring Material

The enduring material will be available from June 28, 2016 - December 28, 2016.

LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:

Identify patient factors that would lead to a high index of suspicion for PAH as the cause of non-specific dyspneic symptoms
Describe recommended testing procedures to establish a PAH diagnosis
Assess the evidence for newer PAH drug treatment regimens with respect to impact on morbidity and mortality
Discuss emerging treatments for PAH and their potential place in therapy


TARGET AUDIENCE

The activity is intended for cardiologists, pulmonologists, radiologists, hospitalists, intensive care specialists, internists, primary care clinicians, and other health care professionals caring for patients with PAH.

ESTIMATED TIME TO COMPLETE
This activity consists of one session, which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to http://www.CardioCareLive.com/. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.


HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FINANCIAL DISCLOSURES

Presenters Disclosures:
Harrison W. Farber, MD, FAHA, FCCP

TBD

   
Moderator TBD
   

University of Cincinnati  
Susan P. Tyler, MEd, CMP, CHCP, Director

Has nothing to disclose

Rick Ricer, MD, CME Physician Reviewer

Has nothing to disclose


PlatformQ Health, Inc.  
Carolyn Skowronski, PharmD, Medical Director

Shareholder: Merck

Karen Greb-Murphy, Program Manager

Has nothing to disclose


DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):
The University of Cincinnati requires the presenter(s) to inform the audience when off-label or unapproved uses of drugs or devices are being discussed. Devices or drugs that are still undergoing clinical trials will be identified as such and will not be portrayed as standard, accepted therapy.

DISCLAIMER:
The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the University of Cincinnati, CardioCareLive, PlatformQ Health or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

CONTACT INFORMATION

Accreditation Support:
Please contact the University of Cincinnati Continuing Medical Education Department at uccme@uc.edu or call 513-558-7277.

Technical Support:
For any technical issues or issues with your CME Certificate, contact CardioCareLive at 877-394-1306 or at Support@CardioCareLive.com

 
CardioCareLive
Watch Connect online with thousands of your peers.
Connect Engage in real-time Q&A with top factuly.
Choose Learn about the latest treatment options.
Connect Earn AMA PRA
Category 1 Credits
™.